The effects of repetitive transcranial magnetic stimulation in obese females with binge eating disorder: a protocol for a double-blinded, randomized, sham-controlled trial

BMC Psychiatry

Angélica Medeiros Claudino¹  Ulrike Schmidt²  Iain Campbell²  Arthur Berberian³  Clarissa Mollinero Picasso¹  Veruska Lastoria Amigo¹  Maria Elisa Gisbert Cury¹  Nara Mendes Estella¹  Mara Fernandes Maranhão¹ 

[1] Eating Disorder Unit, Psychiatry Department, Universidade Federal de São Paulo (UNIFESP), R. Borges Lagoa, 570, 7th floor, São Paulo, SP, Brazil;Section of Eating Disorder, Institute of Psychiatry, King’s College London, Denmark Hill, London, UK;Laboratory Integrative Neuroscience (LiNC), Psychiatric Department, Universidade Federal de São Paulo (UNIFESP), R. Pedro de Toledo, 669, 3rd floor, São Paulo, SP, Brazil

关键词: Eating disorders;    Control inhibition;    Obesity;    Eating disorders;    Hormones;    Neuroimaging;    Transcranial magnetic stimulation;    Binge eating disorder;   

Others  :  1229032
DOI  :  10.1186/s12888-015-0569-8

 received in 2015-06-12, accepted in 2015-07-16,  发布年份 2015

【 摘 要 】

Background

Binge eating disorder is a new category in DSM-5 and highly associated with higher body mass index. The neural mechanisms that underlie binge eating are of great interest in order to improve treatment interventions. Brain mechanisms underlying drug and food craving are suggested to be similar: for example, both are reported to be associated with increased neural activity in the orbitofrontal and anterior cingulate cortex, and a diminished regulatory influence from lateral prefrontal circuits. Several studies have begun to assess the potential benefits of brain stimulation in reducing craving and addictive behaviors. Data from a study of a one-off session of transcranial magnetic stimulation in healthy women identified as strong cravers and of individuals with bulimic-type eating disorders, reported a reduction in food craving and binge eating episodes. This provides support for a more extensive investigation of the potential therapeutic benefits of transcranial magnetic stimulation. Lastly, brain imaging studies and a dimensional approach, will improve understanding of the neural correlates of the disorders and of the mode of action of transcranial magnetic stimulation.

Methods/Design

Sixty eligible obese females, with binge eating disorder, will be randomly allocated to receive 20 sessions of transcranial magnetic stimulation intervention (n = 30) or the sham transcranial magnetic stimulation intervention (n = 30) scattered 3 days/week. Thirty eligible controls will complete the baseline assessment. The primary outcome (number of binge eating episodes) will be assed at each treatment sessions, and 8 weeks after intervention completion (follow-up). It is hypothesized that mean weekly binge-eating episodes will be reduced in the intervention group, compared to the sham group, and that the effect will be maintained at follow-up.

Discussion

Despite the severity associated with Binge Eating Disorder, there are limited treatment options. This study is an important step in the development of more effective treatments. Importantly, the study is the first to investigating binge eating disorder using a dimensional approach, by looking at the different aspects of the disorder, such as behavioral factors, biological factors, brain circuits and chemistry.

Trial registration

Clinical Trials NCT02180984. Registered in July 2014.

【 授权许可】

   
2015 Maranhão et al.

【 图 表 】

Fig. 1.

Fig. 2.

【 参考文献 】

• [1]American Psychological Association: Diagnostic and statistical manual of mental disorders. 5th edition. American Psychiatric Publishing, Arlington, VA; 2013.
• [2]American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 4th edition. American Psychiatric Association, Washington, DC; 2000.
• [3]Darby A, Hay P, Mond J, Quirk F, Buttner P, Kennedy L: The rising prevalence of comorbid obesity and eating disorder behaviors from 1995 to 2005. Int J Eat Disord 2009, 42(2):104-108.
• [4]Agh T, Kovacs G, Pawaskar M, Supina D, Inotai A, Voko Z: Epidemiology, health-related quality of life and economic burden of binge eating disorder: a systematic literature review. Eat Weight Disord 2015, 20:1.
• [5]Palavras MA, Kaio GH, Mari Jde J, Claudino AM: A review of Latin American studies on binge eating disorder. Revista brasileira de psiquiatria 2011, 33(Suppl 1):S81-108.
• [6]Pope HG Jr, Lalonde JK, Pindyck LJ, Walsh T, Bulik CM, Crow SJ, McElroy SL, Rosenthal N, Hudson JI: Binge eating disorder: a stable syndrome. Am J Psychiatry 2006, 163(12):2181-2183.
• [7]Tirico PP, Stefano SC, Blay SL: Qualidade de vida e transtornos alimentares: uma revisão sistemática. Cad Saúde Pública 2010, 26(3):431-449.
• [8]Wilson GT, Wilfley DE, Agras WS, Bryson SW: Psychological treatments of binge eating disorder. Archives of general psychiatry 2010, 67(1):94-101.
• [9]Wilfley DE, Welch RR, Stein RI, Spurrell EB, Cohen LR, Saelens BE, Dounchis JZ, Frank MA, Wiseman CV, Matt GE: A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. Archives of general psychiatry 2002, 59(8):713-721.
• [10]Vocks S, Tuschen-Caffier B, Pietrowsky R, Rustenbach SJ, Kersting A, Herpertz S: Meta-analysis of the effectiveness of psychological and pharmacological treatments for binge eating disorder. Int J Eat Disord 2010, 43(3):205-217.
• [11]Stefano SC, Bacaltchuk J, Blay SL, Appolinario JC: Antidepressants in short-term treatment of binge eating disorder: systematic review and meta-analysis. Eat Behav 2008, 9(2):129-136.
• [12]Reas DL, Grilo CM: Review and meta-analysis of pharmacotherapy for binge-eating disorder. Obesity (Silver Spring) 2008, 16(9):2024-2038.
• [13]Kramer CK, Leitao CB, Pinto LC, Canani LH, Azevedo MJ, Gross JL: Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials. Obes Rev 2011, 12(5):e338-347.
• [14]Cuthbert BN, Insel TR: Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophr Bull 2010, 36(6):1061-1062.
• [15]Gearhardt AN, White MA, Potenza MN: Binge eating disorder and food addiction. Curr Drug Abuse Rev 2011, 4(3):201-207.
• [16]Volkow ND, Wang GJ, Fowler JS, Tomasi D, Baler R: Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci 2012, 11:1-24.
• [17]Marcus MD, Wildes JE: Obesity: is it a mental disorder? Int J Eat Disord 2009, 42(8):739-753.
• [18]Fuhrer D, Zysset S, Stumvoll M: Brain activity in hunger and satiety: an exploratory visually stimulated FMRI study. Obesity (Silver Spring) 2008, 16(5):945-950.
• [19]Volkow ND, Wang GJ, Baler RD: Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci 2011, 15(1):37-46.
• [20]Robbins TW, Gillan CM, Smith DG, de Wit S, Ersche KD: Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends Cogn Sci 2012, 16(1):81-91.
• [21]Hare TA, Camerer CF, Rangel A: Self-control in decision-making involves modulation of the vmPFC valuation system. Science 2009, 324(5927):646-648.
• [22]Lo Sauro C, Ravaldi C, Cabras PL, Faravelli C, Ricca V: Stress, hypothalamic-pituitary-adrenal axis and eating disorders. Neuropsychobiology 2008, 57(3):95-115.
• [23]Illan-Gomez F, Gonzalvez-Ortega M, Orea-Soler I, Alcaraz-Tafalla MS, Aragon-Alonso A, Pascual-Diaz M, Perez-Paredes M, Lozano-Almela ML: Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg 2012, 22(6):950-955.
• [24]Guerre-Millo M: Adiponectin: an update. Diabetes Metab 2008, 34(1):12-18.
• [25]Wang X, Ge A, Cheng M, Guo F, Zhao M, Zhou X, Liu L, Yang N: Increased hypothalamic inflammation associated with the susceptibility to obesity in rats exposed to high-fat diet. Exp Diabetes Res 2012, 2012:847246.
• [26]Walker AJ, Kim Y, Price JB, Kale RP, McGillivray JA, Berk M, Tye SJ: Stress, inflammation, and cellular vulnerability during early stages of affective disorders: biomarker strategies and opportunities for prevention and intervention. Front Psychiatry 2014, 5:34.
• [27]Rosas-Vargas H, Martinez-Ezquerro JD, Bienvenu T: Brain-derived neurotrophic factor, food intake regulation, and obesity. Arch Med Res 2011, 42(6):482-494.
• [28]Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan RM, Jaenisch R: Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 2001, 15(10):1748-1757.
• [29]Edler C, Lipson SF, Keel PK: Ovarian hormones and binge eating in bulimia nervosa. Psychol Med 2007, 37(1):131-141.
• [30]Misra M, Tsai P, Anderson EJ, Hubbard JL, Gallagher K, Soyka LA, Miller KK, Herzog DB, Klibanski A: Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr 2006, 84(4):698-706.
• [31]Misra M, Katzman DK, Estella NM, Eddy KT, Weigel T, Goldstein MA, Miller KK, Klibanski A: Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial. J Clin Psychiatry 2013, 74(8):e765-771.
• [32]Straub RH: The complex role of estrogens in inflammation. Endocr Rev 2007, 28(5):521-574.
• [33]Mobbs O, Iglesias K, Golay A, Van der Linden M: Cognitive deficits in obese persons with and without binge eating disorder. Investigation using a mental flexibility task. Appetite 2011, 57(1):263-271.
• [34]Davis C, Patte K, Curtis C, Reid C: Immediate pleasures and future consequences. A neuropsychological study of binge eating and obesity. Appetite 2010, 54(1):208-213.
• [35]Svaldi J, Brand M, Tuschen-Caffier B: Decision-making impairments in women with binge eating disorder. Appetite 2010, 54(1):84-92.
• [36]Duchesne M, Mattos P, Appolinario JC, de Freitas SR, Coutinho G, Santos C, Coutinho W: Assessment of executive functions in obese individuals with binge eating disorder. Revista brasileira de psiquiatria 2010, 32(4):381-388.
• [37]Galioto R, Spitznagel MB, Strain G, Devlin M, Cohen R, Paul R, Crosby RD, Mitchell JE, Gunstad J: Cognitive function in morbidly obese individuals with and without binge eating disorder. Comprehensive psychiatry 2012, 53(5):490-495.
• [38]Balodis IM, Molina ND, Kober H, Worhunsky PD, White MA, Rajita S, Grilo CM, Potenza MN: Divergent neural substrates of inhibitory control in binge eating disorder relative to other manifestations of obesity. Obesity (Silver Spring) 2013, 21(2):367-377.
• [39]Strauss E, Sherman E, Spreen O: A compendium of neuropsychological tests : administration, norms, and commentary. Oxford University Press, Oxford, New York; 2006.
• [40]Tana MG, Montin E, Cerutti S, Bianchi AM. Exploring cortical attentional system by using fMRI during a Continuous Perfomance Test. Computational intelligence and neuroscience 2010:329213. doi:. 10.1155/2010/329213 webcite
• [41]Guse B, Falkai P, Wobrock T: Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J Neural Transm 2010, 117(1):105-122.
• [42]Demirtas-Tatlidede A, Vahabzadeh-Hagh AM, Pascual-Leone A: Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders? Neuropharmacology 2013, 64:566-578.
• [43]Zanardini R, Gazzoli A, Ventriglia M, Perez J, Bignotti S, Rossini PM, Gennarelli M, Bocchio-Chiavetto L: Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. Journal of affective disorders 2006, 91(1):83-86.
• [44]Nyffeler T, Wurtz P, Pflugshaupt T, von Wartburg R, Luthi M, Hess CW, Muri RM: One-Hertz transcranial magnetic stimulation over the frontal eye field induces lasting inhibition of saccade triggering. Neuroreport 2006, 17(3):273-275.
• [45]Uher R, Yoganathan D, Mogg A, Eranti SV, Treasure J, Campbell IC, McLoughlin DM, Schmidt U: Effect of left prefrontal repetitive transcranial magnetic stimulation on food craving. Biol Psychiatry 2005, 58(10):840-842.
• [46]Walpoth M, Hoertnagl C, Mangweth-Matzek B, Kemmler G, Hinterholzl J, Conca A, Hausmann A: Repetitive transcranial magnetic stimulation in bulimia nervosa: preliminary results of a single-centre, randomised, double-blind, sham-controlled trial in female outpatients. Psychother Psychosom 2008, 77(1):57-60.
• [47]Van den Eynde F, Claudino AM, Mogg A, Horrell L, Stahl D, Ribeiro W, Uher R, Campbell I, Schmidt U: Repetitive transcranial magnetic stimulation reduces cue-induced food craving in bulimic disorders. Biol Psychiatry 2010, 67(8):793-795.
• [48]Downar J, Sankar A, Giacobbe P, Woodside B, Colton P: Unanticipated rapid remission of refractory bulimia nervosa, during high-dose repetitive transcranial magnetic stimulation of the dorsomedial prefrontal cortex: a case report. Front Psychiatry 2012, 3:30.
• [49]Baczynski TP, de Aquino Chaim CH, Nazar BP, Carta MG, Arias-Carrion O, Silva AC, Machado S, Nardi AE: High-frequency rTMS to treat refractory binge eating disorder and comorbid depression: a case report. CNS Neurol Disord Drug Targets 2014, 13(5):771-775.
• [50]Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, et al.: Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain stimulation 2010, 3(4):187-199.
• [51]O'Reardon JP, Blumner KH, Peshek AD, Pradilla RR, Pimiento PC: Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 2005, 66(12):1524-1528.
• [52]Miniussi C, Ruzzoli M: Transcranial stimulation and cognition. Handbook of clinical neurology 2013, 116:739-750.
• [53]Muller MB, Toschi N, Kresse AE, Post A, Keck ME: Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology 2000, 23(2):205-215.
• [54]Baeken C, De Raedt R, Leyman L, Schiettecatte J, Poppe K, Kaufman L, Haes M, Vanderhasselt MA, Anckaert E, D'Haenen H: The impact of one session of HF-rTMS on salivary cortisol in healthy female subjects. World J Biol Psychiatry 2009, 10(4 Pt 2):586-590.
• [55]Evers S, Hengst K, Pecuch PW: The impact of repetitive transcranial magnetic stimulation on pituitary hormone levels and cortisol in healthy subjects. Journal of affective disorders 2001, 66(1):83-88.
• [56]Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, et al.: SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013, 158(3):200-207.
• [57]Sheehan D, Lecrubier Y, Harnett-Sheehan K, Janavs J, Weiller E, Bonara L, Keskiner A, Schinka J, Sheehan M, Dunbar G: Reliability and Validity of the M.I.N.I. International Neuropsychiatric Interview (M.I.N.I.): According to the SCID-P. European Psychiatry 1997, 12:232-241.
• [58]C.G. F: Cognitive Behavior Therapy and Eating Disorders. Guilford Press, NY; 2008.
• [59]Cepeda-Benito A, Gleaves DH, Williams TL, Erath SA: The development and validation of the state and trait food-cravings questionnaires. Behavior Therapy 2000, 31:151-173.
• [60]Freitas S, Lopes C, Coutinho W, Appolinario J: Tradução e adaptação para o português da Escala de Compulsão Alimentar Periódica. Revista brasileira de psiquiatria 2001, 23(4):215-220.
• [61]Stunkard AJ, Messick S: The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985, 29(1):71-83.
• [62]Cappelleri JC, Bushmakin AG, Gerber RA, Leidy NK, Sexton CC, Lowe MR, Karlsson J: Psychometric analysis of the three-factor eating questionnaire-R21: results from a large diverse sample of obese and non-obese participants. Int J Obes (Lond) 2009, 33(6):611-620.
• [63]Natacci LC, Ferreira Junior M: The three factor eating questionnaire - R21: tradução para o português e aplicação em mulheres brasileiras. Revista de Nutrição 2011, 24(3):383-394.
• [64]Latner JD, Mond JM, Kelly MC, Haynes SN, Hay PJ: The loss of control over eating scale: development and psychometric evaluation. Int J Eat Disord 2014, 47(6):647-659.
• [65]Whiteside SP, Lynam DR: The five factor model and impulsivity: using a structural model of personality to understand impulsivity. Personality and Individual Differences 2001, 30(4):669-689.
• [66]Whiteside SP, Lynam DR, Miller JD, Reynolds SK: Validation of the UPPS impulsive behaviour scale: a four-factor model of impulsivity. European Journal of Personality 2005, 19(7):559-574.
• [67]Nogueira CYS, Carvalho AM, Gauer G, Tavares N, Santos RMM, Ginani G, Rivero TS, Moraes PHP, Whiteside SH, Malloy-Diniz LF: Translation and adaptation of impulsive behavior scale (UPPS) to the Brazilian population. Clinical Neuropsychiatry 2013, 10(2):79-85.
• [68]Lovibond SH, Lovibond PF: Manual for the depression anxiety stress scales. 2nd edition. Psychology Foundation, Sydney; 1995.
• [69]Vignola RC, Tucci AM: Adaptation and validation of the depression, anxiety and stress scale (DASS) to Brazilian Portuguese. Journal of affective disorders 2014, 155:104-109.
• [70]Di Pietro M, Silveira DX: Internal validity, dimensionality and performance of the Body Shape Questionnaire in a group of Brazilian college students. Rev Bras Psiquiatr 2009, 31(1):21-24.
• [71]Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34(3):220-233.
• [72]Silveira MF, Almeida JC, Freire RS, Haikal DS, Martins AE: [Psychometric properties of the quality of life assessment instrument: 12-item health survey (SF-12)]. Cien Saude Colet 2013, 18(7):1923-1931.
• [73]Stroop JR: Studies of interference in serial verbal reactions. J Exp Psychology 1935, 18:643-662.
• [74]Hart SJ, Green SR, Casp M, Belger A: Emotional priming effects during Stroop task performance. NeuroImage 2010, 49(3):2662-2670.
• [75]Campbell MK, Elbourne DR, Altman DG: CONSORT statement: extension to cluster randomised trials. BMJ 2004, 328(7441):702-708.
• [76]Angrist JD, Imbens GW, Rubin DB: Identification of causal effects using instrumental variables. Journal of the American statistical Association 1996, 91(434):444-455.
• [77]Jo B, Muthén B: New developments and techniques in structural equation modeling. Modeling of intervention effects with noncompliance: A latent variable approach for randomized trials 2001, 57-87.